1. Home
  2. OPK vs HDL Comparison

OPK vs HDL Comparison

Compare OPK & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • HDL
  • Stock Information
  • Founded
  • OPK 2007
  • HDL 2016
  • Country
  • OPK United States
  • HDL Singapore
  • Employees
  • OPK N/A
  • HDL N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • HDL Restaurants
  • Sector
  • OPK Health Care
  • HDL Consumer Discretionary
  • Exchange
  • OPK Nasdaq
  • HDL Nasdaq
  • Market Cap
  • OPK 1.0B
  • HDL 1.2B
  • IPO Year
  • OPK 1995
  • HDL 2024
  • Fundamental
  • Price
  • OPK $1.40
  • HDL $19.03
  • Analyst Decision
  • OPK Buy
  • HDL
  • Analyst Count
  • OPK 4
  • HDL 0
  • Target Price
  • OPK $2.75
  • HDL N/A
  • AVG Volume (30 Days)
  • OPK 1.9M
  • HDL 2.7K
  • Earning Date
  • OPK 11-06-2025
  • HDL 08-26-2025
  • Dividend Yield
  • OPK N/A
  • HDL N/A
  • EPS Growth
  • OPK N/A
  • HDL 197.81
  • EPS
  • OPK N/A
  • HDL 0.09
  • Revenue
  • OPK $664,029,000.00
  • HDL $805,433,000.00
  • Revenue This Year
  • OPK N/A
  • HDL $14.91
  • Revenue Next Year
  • OPK $0.84
  • HDL $12.41
  • P/E Ratio
  • OPK N/A
  • HDL $206.33
  • Revenue Growth
  • OPK N/A
  • HDL 9.65
  • 52 Week Low
  • OPK $1.11
  • HDL $14.18
  • 52 Week High
  • OPK $2.04
  • HDL $30.00
  • Technical
  • Relative Strength Index (RSI)
  • OPK 53.59
  • HDL 42.25
  • Support Level
  • OPK $1.34
  • HDL $18.80
  • Resistance Level
  • OPK $1.44
  • HDL $19.60
  • Average True Range (ATR)
  • OPK 0.04
  • HDL 0.27
  • MACD
  • OPK 0.00
  • HDL -0.06
  • Stochastic Oscillator
  • OPK 60.00
  • HDL 9.56

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.

Share on Social Networks: